| Autor |
Title
|
| Gunter Wolf, MD |
CELL CYCLE REGULATION OF RENAL HYPERTROPHY
|
| Dr. Aleix Cases |
ADRENOMEDULLIN
|
| Dra. Patricia Fernández-Llama |
AQUAPORINS, MOLECULAR PLAYERS IN THE URINARY CONCENTRATION MECHANISM
|
| Basilia González MD |
PROGRESIÓN DE LA INSUFICIENCIA RENAL CRÓNICA Y ESTRÉS OXIDATIVO
|
| Malvinder S. Parmar MD, FRCPC, FACP |
STRATIGIES TO RETARD PROGRESSION OF CHRONIC KIDNEY DISEASE
|
| Ana PCP Carlotti MD, Desmond Bohn MB, Mogamat Razeen Davids, J-P Mallie MD, Mitchell L. Halperin MD. |
BASIS FOR HYPERNATREMIA IS REVEALED BY A TONICITY BALANCE BUT NOT BY AN ELECTROLYTE-FREE WATER BALANCE
|
| Juan Carlos Ayus, M.D. F.A.C.P. |
ESTADOS HIPOSMOLARES
|
| Ita Pfeferman Heilberg, M.D., PhD |
UPDATE ON DIETARY RECOMMENDATIONS AND MEDICAL TREATMENT OF RENAL STONE DISEASE
|
| Prof. J.Balasubramaniam, M.D.,D.M |
COX-2 INHIBITORS AND NEPHROTOXICITY
|
| Prof. Franz H. Messerli |
ANTIHYPERTENSIVE THERAPY: BETA-BLOCKERS AND DIURETICS
|
| Piero Ruggenenti M.D.*°, Carlos Chiurchiu M.D.°, Giuseppe Remuzzi M.D.*° |
HEMOLYTIC UREMIC SYNDROME
|
| Dra. Assumpta Serra |
ANCA ASSOCIATED VASCULITIS AND ACUTE RENAL FAILURE
|
| Ernesto O. Hoffmann, M.D. |
THE MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN)./LAS GLOMERULONEFRITIS MEMBRANOPROLIFERATIVAS (GNMP).
|
| Cuan Ravinal R, Costa R.S., Pastorello M.T., Coimbra T.M., Coelho E.B., Dantas M., dos Reis M.A. |
CLASS, ACTIVITY AND CHRONICITY INDICES, AND ALPHA-SM ACTIN EXPRESSION AS PROGNOSTIC FACTORS IN LUPUS NEPHRITIS.
|
| Abdías Nicanor Hurtado Aréstegui |
NEFRITIS LUPICA DIAGNOSTICO Y TRATAMIENTO
|
| Franco Ferrario MD |
RENAL INVOLVEMENT IN MIXED CRYOGLOBULINEMIA
|
| Cèlia Badenas MD, Roser Torra MD |
MUTATIONS IN THE COL4A4 AND COL4A3 GENES CAUSE FAMILIAL BENIGN HEMATURIA
|
| Prof. Giorgio Fuiano |
RENAL BIOPSY: INDICATIONS
|
| Francesca Calero MD, J. Ballarín MD |
SINGLE-CENTER EXPERIENCE AND CURRENT INDICATIONS OF RENAL BIOPSY IN ELDERLY PATIENTS
|
| Pedro Abáigar MD PhD. Oscar García Uriarte, MD |
SAL, HIPERTENSIÓN Y RIESGO CARDIOVASCULAR
|
| Dra. Vera Koch |
CASUAL BLOOD PRESSURE AND AMBULATORY BLOOD PRESSURE. MEASUREMENT IN CHILDREN
|
| Dr. Philippe Gosse |
AMBULATORY MONITORING OF QKD TO ASSESS ARTERIAL DISTENSIBILITY
|
| N.A.Tomilina, G.V.Volgina, B.T.Bikbov, Yu.V.Perepechyonickh, I.I.Stenina |
PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY AND GEOMETRIC MODELLING IN PATIENTS WITH CHRONIC RENAL FAILURE
|
| Jordi Bover MD PhD y Montserrat Picazo MD |
RIESGO CARDIONEFROVASCULAR
|
| Philip Kalra FRCP MD |
NEW INSIGHTS INTO THE RENAL FAILURE ASSOCIATED WITH ATHEROSCLEROTIC RENOVASCULAR DISEASE (ARVD)
|
| RE Tracy, M.D. |
RENOVASCULOPATHIES AND THE RISE OF BLOOD PRESSURE WITH AGE.
|
| Dra Guillermina Barril Cuadrado, Dr. Sergio R. Acchiardo, Dr. Secundino Cigarrán Guldrís, Dr Juan Manuel Lopez Gomez, Dr. Victor Lorenzo Sellares, Francisco Caravaca |
ROUND TABLE ON: CLINICAL MANAGEMENT OF PATIENTS IN PREDIALYSIS STATE
|
| Elias Thodis MD, Dimitrios G. Oreopoulos, MD, PhD, FRCPC, FACP, FRCPS |
PERITONEAL DIALYSIS: BETTER EQUAL OR WORSE THAN HAEMODIALYSIS?
|
| Zbylut J. Twardowski, MD, PhD, FACP |
PERITONEAL DIALYSIS ACCESS - IS IT TIME TO MOVE UP?
|
| José Carolino Divino Filho, MD, PhD |
PERITONEAL DIALYSIS SOLUTIONS.
|
| Javier de Arteaga MD |
FALLO DE ULTRAFILTRACION EN DIALISIS PERITONEAL
|
| Dr. Rafael Selgas |
ENCAPSULATING SCLEROSING PERITONITIS (ESP). EARLY DIAGNOSIS
|
| Moreno Sanz C, PhD., EBSQ. |
LAPAROSCOPIC PLACEMENT OF PERITONEAL DIALYSIS CATHETERS.
|
| Moreno Sanz C, PhD., EBSQ, eoane González JB, PhD |
ACUTE ABDOMEN IN PATIENTS WITH PERITONEAL DIALYSIS.
|
| Roland Pilgram MD and Prof. Daniel Schneditz PhD |
FEEDBACK CONTROL OF HEMODIALYSIS.
|
| Gerardo Torres Torres MD |
STRESS OXIDATIVO EN HEMODIALISIS: PREVENCION Y ESTRATEGIAS DE TRATAMIENTO.
|
| Dres. Alberto M. Alles, Héctor R. Hidalgo, Sergio Marinovich |
MANEJO POST-OPERATORIO DEL PACIENTE CON HIPERPARATIROIDISMO SECUNDARIO URÉMICO
|
| Rafael Pérez-García, Patrocinio Rodríguez-Benítez |
LA CALIDAD DEL LÍQUIDO DE HEMODIÁLISIS
|
| Daniel Schneditz, Ph.D. |
TEMPERATURE AND HEMODIALYSIS
|
| Garcia-Valdecasas Bernal J. C., Quiroga Subirana P.A., Abaigar P., Garcia-Valdecasas Valverde J. , Kimmel P.L. |
DIFFERENCES IN SOLUTE CLEARANCE BETWEEN HIGH FLUX - HIGH EFFICIENCY DIALYSIS AND ON LINE HEMODIAFILTRATION.
|
| Khaja H. Mujtaba Quadri, MD and Sameer Omar Huraib, MD |
IS THERE A NEED FOR ESTABLISHING A FORMAL NEPHROLOGIST-DIRECTED PRIMARY CARE PROGRAM IN DIALYSIS UNITS?
|
| Dr. Mariano Rodríguez Portillo. |
ROLE OF PHOSPHORUS IN THE PATHOGENESIS OF SECUNDARY HYPERPARATHYROIDISM
|
| Masafumi Fukagawa, M.D., Ph.D., FJSIM |
MECHANISMS OF SKELETAL RESISTANCE TO PTH IN UREMIA
|
| Juan F. Navarro González, Carmen Mora Fernández |
ENFERMEDAD OSEA ADINAMICA E HIPOPARATIROIDISMO RELATIVO EN LA UREMIA
|
| Dr. José Ramón Armas Padrón. H.U Virgen Macarena y Facultad de Medicina de la Universidad de Sevilla |
PAPEL DE LA BIOPSIA OSEA EN EL DIAGNOSTICO DE LA OSTEODISTROFIA RENAL
|
| Prof. Dra. Clotilde Druck Garcia |
RENAL TRANSPLANTATION IN CHILDREN LESS THAN 6 YEARS OF AGE
|
| Dr Douglas R McLean |
MATHEMATICAL MODELLING AND SIMULATION OF BIOLOGICAL SYSTEMS IN RENAL TRANSPLANTATION AND RENAL DISEASE
|
| Rubina Naqvi MBBS, MD |
DONOR SELECTION
|
| Dr. Lluis Guirado |
USE OF CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AS A MARKER FOR PREEMPTIVE TREATMENT
|
| R.Solà MD. |
UTILIZATION OF SUBOPTIMAL KIDNEYS (AGED DONORS) IN TRANSPLANTATION
|
| Carolina Frías, Ricardo Lauzurica. |
CLINICAL VALUE OF EPSTEIN-BARR VIRUS (EBV) LOAD IN KIDNEY TRANSPLANTATION / VALOR CLINICO DE LA CARGA VIRAL DEL VIRUS DE EPSTEIN-BARR (VEB) EN EL TRASPLANTE RENAL.
|
| Dra. Stella M. Dieguez |
MICROALBUMINURIA SIGNO Y ELEMENTO CAUSANTE DE PROGRESION DE LA ENFERMEDAD RENAL
|
| Yousef A. Boobes, MD |
INFORMATICS AND NEPHROLOGY
|
| Hélio Teixeira |
HOLISM AND MEDICINE
|
